Clinical Laboratory, The Affiliated Shunde Hospital of Jinan University, Foshan, Guangdong, PR People's Republic of China.
Clinical Laboratory Center, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, PR People's Republic of China.
Hematology. 2022 Dec;27(1):1026-1031. doi: 10.1080/16078454.2022.2119736.
Thalassemia is a monogenic genetic disorder with a high prevalence in populations in the southern region of China. The thalassemia gene prevalence rate in the Baise population in China is high, and several rare gene variants have been detected in the population of this region during routine testing by our study group. To accurately reveal the thalassemia gene variants carried by the population in Baise, and to provide a basis for the formulation of thalassemia prevention and control policies in the region, we conducted a more comprehensive study in a randomly selected population.
In all, 4,800 randomized individuals were recruited for testing from Baise, and the detection of hot spot thalassemia genetic variants were performed by Gap-PCR and PCR-RDB methods, combined with the relative quantification of homologous fragments and AS-PCR to expand the detection range. The prevalence of thalassemia variants in this population was 24.19%, among which 16.69% of individuals carried α-thalassemia gene variants alone, 5.62% carried β-thalassemia gene variants alone, and 1.88% carried both variants.
The use of positive primary screening combined with hot spot gene variant detection alone can result in a certain degree of missed detection. In the prevention and control of thalassemia in the region, testing institutions need to pay attention to the detection of rare thalassemia gene variants such as ααα, ααα, -α, -α, β, β, and β, to provide more accurate genetic counseling advice to subjects.
地中海贫血是一种单基因遗传病,在中国南方地区的人群中发病率较高。本研究组在对中国百色人群进行常规检测时,发现该人群中海贫血基因的携带率较高,存在几种罕见的基因变异。为准确揭示百色人群携带的地中海贫血基因变异,为该地区制定地中海贫血防控政策提供依据,我们在随机选择的人群中进行了更全面的研究。
共从百色地区随机抽取 4800 名个体进行检测,采用 Gap-PCR 和 PCR-RDB 方法检测热点地中海贫血遗传变异,并结合同源片段相对定量和 AS-PCR 进行扩展检测范围。该人群地中海贫血变异的患病率为 24.19%,其中 16.69%的个体单独携带α-地中海贫血基因变异,5.62%的个体单独携带β-地中海贫血基因变异,1.88%的个体同时携带两种变异。
单纯采用正向初筛联合热点基因变异检测会导致一定程度的漏检。在该地区地中海贫血的防控中,检测机构需要注意检测ααα、ααα、-α、-α、β、β、β等罕见地中海贫血基因变异,为受检者提供更准确的遗传咨询建议。